Are two better than one? Angiotensin-converting enzyme inhibitors plus angiotensin receptor blockers for reducing blood pressure and proteinuria in kidney disease

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue SUPPL. 1, 2008, Pages

  Linas, Stuart L ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

DRUG COMBINATION; HUMAN; HYPERTENSION; KIDNEY DISEASE; PROTEINURIA; REVIEW;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION; KIDNEY DISEASES; PROTEINURIA;

EID: 40149111007     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03270807     Document Type: Review

References (19)

1. Mogensen CE, Neldam S, Tikkanen, I, Oren S, Viskoper R, Watts RW, Cooper ME: Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: The Candesartan and Lisinopril Microalbuminuria. (CALM) Study. BMJ 321: 1440-1444, 2000
2. Jacobsen P, Andersen S, Jensen BR, Parving HH: Additive effect of ACE inhibition and angiotensin H receptor blockade in type 1 diabetic patients with diabetic nephropathy. J Am Soc Nephrol 14: 992-999, 2003
3. Jacobsen P, Andersen S, Rossing K, Jensen BR, Parving HH: Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy. Kidney Int 63: 1874-1880, 2003
4. Agarwal R: Add-on angiotensin receptor blockade with maximized ACE inhibition. Kidney Int 59: 2282-2289, 2001
5. Campbell R, Sangalli F, Perticucci E, Aros C, Viscarra C, Perna A, Remuzzi A, Bertocchi F, Fagiani L, Remuzzi G, Ruggenenti P: Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies. Kidney Int 63: 1094-1103, 2003
6. Esnault VLM, Ekhlas A, Delcroix C, Moutel MG, Nguyen JM: Diuretic and enhanced sodium restriction results in improved antiproteinuric response to RAS blocking agents. J Am Soc Nephrol 16: 474-481, 2005
7. Doulton TW, He FJ, MacGregor GA: Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension. Hypertension 45: 880-886, 2005
8. Heeg JE, Dejong PE, Van Der Hem GK, De Zeeuw D: Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int 36: 272-279, 1989
9. Buter H, Hemmelder MH, Navis G, de Jong PE, de Zeeuw D: The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide. Nephrol Dial Transplant 13: 1682-1685, 1998
10. Russo D, Minutolo R, Pisani A, Esposito R, Signoriello G, Andreucci M, Balletta MM: Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy. Am J Kidney Dis 38: 18-25, 2001
11. Laverman GD, Navis G, Henning RH, De Jong PE, De Zeeuw D: Dual renin-angiotensin system blockade at optimal doses for proteinuria. Kidney Int 62: 1020-1025, 2002
12. Forclaz A, Maillard M, Nussberger J, Brunner HR, Burnier M: Angiotensin II receptor blockade: Is there truly a benefit of adding an ACE inhibitor? Hypertension 41: 31-36, 2003
13. Stergiou GS, Skeva II, Baibas NM, Roussias LG, Kalkana CB, Achimastos; AD, Mountokalakis TD: Additive hypotensive effect of angiotensin-converting enzyme inhibition and angiotensin-receptor antagonism in essential hypertension. J Cardiovasc Pharmacol 35: 937-941, 2000
14. Nakao N, Yoshimura A, Morita H, Takeda M, Kayano T, Ideura T: Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): A randomized controlled trial. Lancet 361: 117-124, 2003
15. Krimholtz MJ, Karalliedde J, Thomas S, Bilous R, Viberti G: Targeting albumin excretion rate in the treatment of the hypertensive diabetic patient with renal disease. J Am Soc Nephrol 16: S42-S47, 2005
16. Ruilope LM, Aldigier JC, Ponticelli C, Oddou-Stock P, Botteri F, Mann JF: Safety of the combination of valsartan and benazepril in patients with chronic renal disease. J Hypertension 18: 89-95, 2000
17. MacKinnon M, Shurraw S, Akbari A, Knoll GA, Jaffey J, Clark HD: Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: A systematic review of the efficacy and safety. Am J Kidney Dis 48: 8-20, 2006
18. Yancy CW, Fowler MB, Colucci WS, Gilbert EM, Bristow MR, Cohn JN, Lukas MA, Young ST, Packer M, US Carvedilol Heart Failure Study Group: Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure. N Engl J Med 344: 1358-1365, 2001
19. Exner DV, Dries DL, Domanski MJ, Cohn JN: Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. N Engl J Med 344: 1351-1357, 2001